Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
Clinical trial NCT01747629 · COMPLETED
Trial details
- NCT number
- NCT01747629
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-10-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.